#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Waldenstrom's macroglobulinaemia Myocarditis Cardiac amyloidosis Craniopharyngioma Aplastic anaemia Osteomyelitis Antiphospholipid antibodies Hypoparathyroidism Aicardi-Goutieres syndrome Netherton's syndrome Deafness Desmoid tumour Urea cycle disorder Short stature homeobox gene mutation Glomerulonephritis acute More trials…

    Learn about Rare Diseases

    Retinoblastoma – Life with Disease Lennox-Gastaut syndrome – Treatment Ocular melanoma – Treatment CADASIL – Treatment Haemophilia A without inhibitors – Life with Disease Hereditary ataxia Mast cell activation syndrome – Diagnostics Choroid melanoma Extranodal marginal zone B-cell lymphoma (MALT type) – Treatment Bronchopulmonary dysplasia – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Rezvilutamide Wt1/Il15/Il15Ra Mrna Dc Protease Colistin Sulfate Mk-1942 GSKVX000000044501 SULBACTAM SODIUM Ixazomib Citrate Prednisone Acetate Tramadol Hydrochloride Gebasaxturev Ranitidine Hydrochloride Sapropterin Dihydrochloride Secukinumab Amylase Insulin Icodec Isis 696844 Lenacapavir Cetuximab Bicalutamide More therapies…

    Learn about Your Condition

    Coronary artery bypass Colon cancer stage II Angiopathy Colorectal cancer stage III Anogenital dysplasia Schizoaffective disorder Infection T-cell type acute leukaemia Mast cell activation syndrome Oral neoplasm Osteosarcoma metastatic Propionic acidaemia K-ras gene mutation Fibrous dysplasia of bone Incontinence More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A study testing TRIV-509 compared to placebo in adults with moderate to severe atopic dermatitis

    Not recruiting

    2 1
    Investigated Drugs:
    • HUMAN IGG1 BISPECIFIC MONOCLONAL ANTIBODY AGAINST KALLIKREIN-5 AND KALLIKREIN-7
    Bulgaria Czechia Hungary Poland

  • A Study of Brelovitug Compared to Delayed Treatment in Patients with Chronic Hepatitis Delta Infection

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Bjt-778
    Belgium Bulgaria Hungary

  • A Study of Mevrometostat and Enzalutamide for Men with Metastatic Castration-Sensitive Prostate Cancer Who Have Not Received Hormonal Therapy or Chemotherapy

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hormone-dependent prostate cancer
    • Prostate cancer metastatic
    Investigated Drugs:
    • 5,8-Dichloro-2-[(4-Methoxy-6-Methyl-2-Oxo-1,2-Dihydropyridin-3-Yl)Methyl]-7-[(R)-Methoxy(Oxetan-3-Yl)Methyl]-3,4-Dihydroisoquinolin-1(2H)-One
    • Enzalutamide
    Belgium Bulgaria Czechia Finland France Germany +6

  • A study testing ALN-4324 for safety and effectiveness in overweight to obese patients with type 2 diabetes

    Not recruiting

    2 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • ALN-4324
    Germany Poland

  • Study of Trontinemab Compared to Placebo for Patients with Early Symptomatic Alzheimer’s Disease

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Florbetapir (18F)
    • TRONTINEMAB
    • Florbetaben (18F)
    Denmark France Germany Italy The Netherlands Poland +1

  • Study of ianalumab for adults with primary immune thrombocytopenia or warm-antibody autoimmune hemolytic anemia who previously responded to ianalumab

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Immune thrombocytopenia
    • Warm autoimmune haemolytic anaemia
    Investigated Drugs:
    • Entecavir
    • Ianalumab
    • Danazol
    Belgium Bulgaria Czechia France Germany Hungary +3
Previous Page
1 … 929 930 931 932 933 … 1,675
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!